Atherosclerosis severity but not undiagnosed diabetes predicts new cardiovascular events of subjects in secondary cardiovascular prevention

Atherosclerosis

Volumn 223, Issue 2, 2012, Pages 448-453

  Rizza, Stefano ^a   Copetti, Massimiliano ^b   Cardellini, Marina ^a   Porzio, Ottavia ^a   Luzi, Alessio ^a   Pecchioli, Chiara ^a   Martelli, Eugenio ^a   Valentini, Alessia ^a   Ippoliti, Arnaldo ^a   Romeo, Francesco ^a   Pellegrini, Fabio ^b,c   Lauro, Davide ^a   Lauro, Renato ^a   Federici, Massimo ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^c Santa Maria Imbaro   (Italy)

Author keywords

A1c; Atherosclerosis; Cardiovascular risk; CV; Diabetes; DM2; Inflammation; MI; OGTT

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART INFARCTION; HEMOGLOBIN BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVASCULARIZATION; SECONDARY PREVENTION; SMOKING HABIT; STROKE; SYSTOLIC BLOOD PRESSURE;

AGED; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; ITALY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; SECONDARY PREVENTION; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT FAILURE;

EID: 84864750349     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.04.019     Document Type: Article

References (20)

1. Gu K., Cowie C.C., Harris M.I. Diabetes and decline in heart disease mortality in US adults. JAMA 1999, 281:1291-1297.
2. Wingard D.L., Barrett-Connor E. Heart disease and diabetes. National Institutes of health, National Institute of diabetes and digestive and kidney disease. Diabetes in America 1995, The National Diabetes Data Goup, Rockville, NIH publication no. 95-1468, p. 429-448. 2nd ed.
3. Dagenais G.R., Lu J., Faxon D.P., et al. Effect of optimal medical treatment with or without coronary revascularization on Angina and subsequent revascularization in patients with type 2 diabetes mellitus and stable ischemic heart disease. Circulation 2011, 123(14):1492-1500.
4. Marsh J.D., Keyrouz S.G. Stroke prevention and treatment. J Am Coll Cardiol 2010, 56(9):683-691.
5. Haffner S.M., Lehto S., Ronnemaa T., Pyorala K., Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998, 339(4):229-234.
6. Whiteley L., Padmanabhan S., Hole D., Isles C. Should diabetes be considered a coronary heart disease risk equivalent? Results from 25 years of follow-up in the Renfrewand Paisley Survey. Diabetes Care 2005, 28(7):1588-1593.
7. Norhammar A., Tenerz A., Nilsson G., et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002, 359(9324):2140-2144.
8. Rizza S., Cardellini M., Martelli E., et al. Occult impaired glucose regulation in patients with atherosclerosis is associated to the number of affected vascular districts and inflammation. Atherosclerosis 2010, 212(1):316-320.
9. Bartnik M., Malmberg K., Norhammar A., Tenerz A., Ohrvik J., Rydén L. Newly detected abnormal glucose tolerance: an important predictor of long-term out come after myocardial infarction. Eur Heart J 2004, 25(22):1990-1997.
10. Lim L.S., Haq N., Mahmood S., Hoeksema L., ACPM Prevention Practice Committee; American College of Preventive Medicine Atherosclerosis cardiovascular disease screening in adults. American college of preventive medicine position statement on preventive practice. Am J Prev Med 2011, 40(3):380-381.
11. U.S.Preventive services task force Screening for coronary heart disease: recommendation statement. Ann Inter Med 2004, 140(7):569-572.
12. Greenland P., Bonow R.O., Brundage B.H., et al. American College of Cardiology Foundation Clinical Consensus Task Force (ACCF/AHA Writing Committee to update the 2000 Expert Consensus Document on electron Bean Computed Tomography); Society of Atherosclerosis Imaging and Prevention; Society of Cardiovascular Computed Tomography ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of American college of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to update the 2000 Expert Consensus Document on electron Bean Computed Tomography). Circulation 2007, 115(3):402-426.
13. Third report of the National Cholesterol Education Program (NCEP) Expert panel of detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III): executive summery 2001, NIH, Bethesda MD.
14. Society for Vascular Surgery. SVS position statement on vascular screening. http://www.vascularweb.org/patients/screenings/SVSPositionStatementonVascularScreening.html.
15. Bhatt D.L., Eagle K.A., Ohman E.M., et al. Reach Registry Investigator Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherotrombosis. JAMA 2010, 304(12):1350-1357.
16. Consensus Committee Consensus Statement on the Worldwide Standardization of the Hemoglobin A1C Measurement. The American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation. Diabetes Care 2007, 30:2399-2400.
17. He L.P., Tang X.Y., Ling W.H., Chen W.Q., Chen Y.M. Early C-reactive protein in the prediction of long-term outcomes after acute coronary syndrome: a meta-analysis of longitudinal studies. Heart 2010, 96(5):339-346.
18. UK Prospective diabetes study (UKPDS) Intensive blood glucose control with sulpholynureas or insulin compared with conventional treatment and risk of complication in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352(9131):837-853. Erratum in: Lancet 1999;354(9178):602.
19. Duckworth W., Abraira C., Moritz T., et al. VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009, 361(10):1024-1025.
20. ADVANCE Collaborative Group, Patel A., MacMahon S., Chalmers J., et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008, 358(24):2560-2572.